The CEO Who Capped a $37 Billion Recovery With a Cancer Drug Deal
Avigan influenza tablets, produced by Fujifilm Holdings Corp., are arranged for a photograph at the company’s headquarters in Tokyo. (Photographer: Akio Kon/Bloomberg)

The CEO Who Capped a $37 Billion Recovery With a Cancer Drug Deal

(Bloomberg) -- The future looked bleak for Japanese drugmaker Daiichi Sankyo Co. when George Nakayama took over as chief executive officer in 2010.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.